11:24 AM EST - Oncolytics Biotech® Inc. : Currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced that it will have an oral presentation at the 12th Annual International Oncolytic Virus Conference. The conference takes place at the Mayo Civic Center in Rochester, Minnesota, from October 9 - 12. Oncolytics Biotech® Inc.
shares T.ONC are trading down $0.01 at $0.84.
